India remains on USTR Priority Watch List
But no OCR this year ... as yet
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Wockhardt recalls 12 drugs in US made at two India units
Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana…
US FDA public meeting on June 15 on reauthorisation of GDUFA
FDA has invited public suggestions on the GDUFA programme and the features FDA should propose for the next programme
NPPA threatens action against companies yet to register in IPDMS
More than half of top 100 pharma companies yet to register
US FDA nod for generics of Abilify
To market generic aripiprazole in multiple strengths and dosage forms to treat mental disorders
Rusan Pharma launches first ‘Made in India’ NRT patch 2baconil
Designed for humid climates; to co-partner with Brazilian govt in early May
CPhI to conduct 3rd Annual Pharma Project Management Conference
To focus on addressing challenges faced by project managers while handling projects in complex environments
Basic science research to be the thrust area of Modi Government
Vardhan asks scientists at IACS to accept new challenges
IDMA organises workshop on Laboratory Data Integrity in Mumbai
More than 150 participants from different pharma companies participated